ClinicalTrials.gov record
Terminated Phase 2 Interventional

Study in Adult Asthmatic Patients With Allergic Bronchopulmonary Aspergillosis

ClinicalTrials.gov ID: NCT03960606

Public ClinicalTrials.gov record NCT03960606. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 15, 2026, 2:51 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety, Tolerability, & Pharmacokinetics of Itraconazole Administered as a Dry Powder for Inhalation (PUR1900) in Asthmatic Patients With ABPA

Study identification

NCT ID
NCT03960606
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pulmatrix Inc.
Industry
Enrollment
7 participants

Conditions and interventions

Interventions

  • PUR1900 Combination Product
  • Placebo Combination Product

Combination Product

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 30, 2019
Primary completion
Jul 13, 2020
Completion
Jul 13, 2020
Last update posted
Aug 26, 2021

2019 – 2020

United States locations

U.S. sites
9
U.S. states
8
U.S. cities
9
Facility City State ZIP Site status
National Jewish Health Denver Colorado 80206
Yale University School of Medicine New Haven Connecticut 06520
Integrity Clinical Research Center Inc. Hialeah Florida 33015
Heuer M.D Research Inc. Miami Lakes Florida 32819
Infinite Clinical Trials Roswell Georgia 30076
University Consultants In Allergy and Immunology Chicago Illinois 60612
Laporte County Institute for Clinical Research Michigan City Indiana 46360
Montefiore Medical Center The Bronx New York 10461
University of Texas Medical Branch at Galveston Galveston Texas 77555

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03960606, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 26, 2021 · Synced May 15, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03960606 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →